💊 Nitrate PDE5 Inhibitor Drug Interaction Simulator
This simulation illustrates the dangerous interactions between nitrates and PDE5 inhibitors. It highlights the risks associated with combining these medications, providing critical information for healthcare providers to avoid adverse effects and ensure patient safety.
Sildenafil Blocks cGMP Breakdown In Smooth Muscle
PDE5 inhibitors raise cGMP, causing mild, safe vasodilation.
- 5–8: Systolic BP drop (mmHg typical)
- >80%: PDE5 inhibition (enzyme blocked)
- 30–60: Onset of action (minutes)
- ~4: Half-life (hours (sildenafil))
How PDE5 inhibitors work
Sildenafil blocks PDE5 from degrading cGMP in vessels.
Alone, PDE5 inhibitors cause only modest, safe vasodilation.
Localized vascular effect
Effect concentrates in corpus cavernosum smooth muscle.
Systemic circulation stays stable
Blood pressure drops slightly but stays in safe range.
Nitroglycerin Donates Nitric Oxide To Vessel Walls
Nitrates release nitric oxide, also raising cGMP modestly.
- 10–15: Systolic BP drop (mmHg typical)
- 1–3: NO donation onset (min sublingual)
- Direct: Guanylate cyclase (activation)
- ~2–3: Half-life (min (nitroglycerin))
Nitric oxide release mechanism
Nitrates metabolize into nitric oxide inside vessel walls.
Alone, nitrates cause controlled, reversible vasodilation.
Direct guanylate cyclase activation
NO activates guanylate cyclase, raising cGMP directly.
Coronary and systemic dilation
Vessels widen enough to relieve angina safely.
Both Drugs Raise cGMP Through The Same Pathway
Taking both drugs together activates one pathway twice.
- >90%: Combined cGMP (activation)
- Shared: Pathway overlap (cGMP cascade)
- Contra-: Risk class (indicated)
- Minutes: Crisis onset (after dosing)
Shared molecular pathway
Both drugs converge on the nitric oxide–cGMP cascade.
Combining nitrates and PDE5 inhibitors is a known contraindication.
No independent regulation
Neither drug can compensate for the other's excess.
Vasculature-wide exposure
Effects now reach vessels throughout the entire body.
Systemic Vessels Dilate Far Beyond Safe Limits
Vessel walls relax excessively across the whole body.
- >60%: Tone lost (vascular tone)
- Significant: Venous pooling (blood pools)
- Sharply: Cardiac preload (reduced)
- Insufficient: Reflex response (to compensate)
Excessive smooth muscle relaxation
Vessel walls lose nearly all baseline muscular tone.
Synergy multiplies the effect, it does not simply add it.
Venous pooling and reduced return
Blood pools in veins, reducing return to the heart.
Compensation begins failing
Baroreceptor reflexes cannot offset the sudden drop.
Blood Pressure Collapses Toward Cardiovascular Shock
Severe hypotension threatens organ perfusion and life.
- <70: Systolic BP (mmHg possible)
- MI / stroke: Major risk (organ ischemia)
- IV fluids: Emergency care (+ vasopressors)
- Significant: Mortality risk (if untreated)
Cardiovascular collapse risk
Organs lose adequate blood flow and oxygen delivery.
This is a documented cause of death from drug interaction.
Emergency management
Treatment requires fluids and vasopressor support urgently.
Absolute prevention
Patients must never combine these drug classes.
This simulation illustrates the dangerous interactions between nitrates and PDE5 inhibitors. It highlights the risks associated with combining these medications, providing critical information for healthcare providers to avoid adverse effects and ensure patient safety.
2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install